Concentrix (NASDAQ:CNXC) Announces Quarterly Earnings Results, Misses Estimates By $0.06 EPS

Concentrix (NASDAQ:CNXC) released its earnings results on Thursday. The company reported $2.70 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.06), RTT News reports. The company had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.38 billion. Concentrix had a net margin of 2.54% and a return on equity of 16.51%. Concentrix’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $2.69 earnings per share. Concentrix updated its FY 2025 guidance to 11.530-11.760 EPS and its Q3 2025 guidance to 2.800-2.910 EPS.

Concentrix Trading Down 6.2%

Shares of Concentrix stock opened at $51.71 on Friday. Concentrix has a twelve month low of $36.28 and a twelve month high of $77.00. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 1.22. The business has a 50-day moving average price of $53.86 and a 200-day moving average price of $49.47. The firm has a market cap of $3.30 billion, a price-to-earnings ratio of 14.21, a PEG ratio of 0.71 and a beta of 0.56.

Concentrix Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 5th. Shareholders of record on Friday, July 25th will be issued a dividend of $0.3328 per share. This represents a $1.33 annualized dividend and a dividend yield of 2.57%. The ex-dividend date of this dividend is Friday, July 25th. Concentrix’s dividend payout ratio (DPR) is presently 33.33%.

Insider Buying and Selling

In other news, CEO Christopher A. Caldwell purchased 1,000 shares of the business’s stock in a transaction on Monday, April 21st. The stock was acquired at an average price of $46.00 per share, for a total transaction of $46,000.00. Following the acquisition, the chief executive officer now directly owns 303,362 shares of the company’s stock, valued at $13,954,652. This represents a 0.33% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Cormac J. Twomey sold 500 shares of the firm’s stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $57.06, for a total value of $28,530.00. Following the transaction, the executive vice president now owns 38,130 shares of the company’s stock, valued at $2,175,697.80. This represents a 1.29% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,944 shares of company stock worth $1,510,158. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On Concentrix

Several institutional investors have recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. grew its position in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares in the last quarter. Focus Partners Wealth purchased a new stake in shares of Concentrix in the first quarter valued at approximately $781,000. Royal Bank of Canada boosted its holdings in shares of Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after purchasing an additional 4,133 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after purchasing an additional 181,546 shares during the period. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CNXC. Robert W. Baird boosted their price objective on Concentrix from $62.00 to $72.00 and gave the company an “outperform” rating in a research report on Thursday. Bank of America decreased their target price on Concentrix from $65.00 to $61.00 and set a “neutral” rating on the stock in a research note on Friday. Barrington Research reissued an “outperform” rating and issued a $54.00 price target on shares of Concentrix in a report on Tuesday. Finally, Wall Street Zen downgraded Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, June 21st. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $66.75.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.